Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
出版信息
PLoS One. 2019 Nov 26;14(11):e0225971. doi: 10.1371/journal.pone.0225971. eCollection 2019.
Abstract
摘要
相似文献
1
Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
PLoS One. 2019 Nov 26;14(11):e0225971. doi: 10.1371/journal.pone.0225971. eCollection 2019.
2
Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
PLoS One. 2016 Apr 28;11(4):e0154419. doi: 10.1371/journal.pone.0154419. eCollection 2016.
3
Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Cytokine. 2004 Jul 7;27(1):7-14. doi: 10.1016/j.cyto.2004.03.009.
4
Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
Liver Transpl. 2000 Mar;6(2):222-8. doi: 10.1002/lt.500060204.
5
[Treatment of recurrent hepatitis C virus infection after liver transplantation].
Orv Hetil. 2007 Oct 7;148(40):1875-81. doi: 10.1556/OH.2007.28217.
6
Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels.
Mediators Inflamm. 2001 Feb;10(1):37-41. doi: 10.1080/09629350124104.
7
Recurrent disease after liver transplantation.
Semin Gastrointest Dis. 1998 Jul;9(3):86-109.
8
Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients.
Hepatology. 1997 Aug;26(2):432-6. doi: 10.1002/hep.510260225.
9
Management of recurrent hepatitis C after liver transplantation: a concise review.
Am J Gastroenterol. 2000 Sep;95(9):2164-70. doi: 10.1111/j.1572-0241.2000.02296.x.
10
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
Liver Transpl Surg. 1997 Jul;3(4):398-406. doi: 10.1002/lt.500030407.
本文引用的文献
1
Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.
BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473.
2
Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
PLoS One. 2016 Apr 28;11(4):e0154419. doi: 10.1371/journal.pone.0154419. eCollection 2016.
Zotero 插件